Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mapping recovery: new study follows head and neck cancer patients after facial reconstruction

NCT ID NCT06771336

Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study observes 200 adults with head and neck cancer who need facial reconstruction using a free bone flap after surgery. Researchers will track their medical visits, treatments, and costs over time using national health data. The goal is to describe typical care pathways and identify patterns to improve future care. No new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors and hospitals design better, more efficient care plans for patients needing facial reconstruction after head and neck cancer surgery.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve patient outcomes. Results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participation in the protocol will be offered to all patients meeting the eligibility criteria during the 3-year inclusion period. It is planned to include 200 operated patients, including 50 treated by maxillectomy and 150 treated by mandibulectomy. Nine French cancer centers and university hospitals will participate in the project: the University Hospitals of Toulouse, Amiens, Rouen, Lille, Montpellier, Nantes, the Gustave Roussy Institute, the Antoine Lacassagne Center (Nice) and the Hospices Civil de Lyon.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with oral cavity cancer or maxillary and/or oropharynx cancer * Eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction. * Patient whose disease is classified Stage cT4a, N0 to N3, M0 * Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose) * Age greater than or equal to 18 years * Patient affiliated to a Social Security scheme in France * Patient having given written informed consent Non-inclusion Criteria: * Patient having any situation considered by the doctor as a reason for non-inclusion such as stenosis of the leg tripod not allowing reconstruction by fibula, one or more comorbidity(s) not allowing reconstruction by free bone flap or making this reconstruction too much risk * Patient having had previous radiotherapy * Patient with severe coagulation disorders * Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms maxillary neoplasm oral cavity cancer oropharynx cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Head and neck cancers

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    NOT_YET_RECRUITING

    Nice, 06189, France

  • Hospices Civils de Lyon

    NOT_YET_RECRUITING

    Lyon, 69004, France

  • Institut Gustave Roussy

    NOT_YET_RECRUITING

    Villejuif, 94805, France

  • University hospital of Amiens- Picardie

    NOT_YET_RECRUITING

    Amiens, 80054, France

  • University hospital of Lille

    NOT_YET_RECRUITING

    Lille, 59037, France

  • University hospital of Montpellier

    NOT_YET_RECRUITING

    Montpellier, 34090, France

  • University hospital of Nantes

    NOT_YET_RECRUITING

    Nantes, 44093, France

  • University hospital of Rouen

    NOT_YET_RECRUITING

    Rouen, 76000, France

  • University hospital of Toulouse

    RECRUITING

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.